ArticleJournal of virology2022

A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.

Zhujun Ao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.